Home  »  Trending   »  Analyzing the Price-to-Earnings Ratio of Panbela T...

Analyzing the Price-to-Earnings Ratio of Panbela Therapeutics Inc. (PBLA)

The 36-month beta value for PBLA is also noteworthy at 1.08.

The average price estimated by analysts for PBLA is $10.00, which is $9.37 above than the current price. The public float for PBLA is 5.91M, and at present, short sellers hold a 14.53% of that float. The average trading volume of PBLA on March 15, 2023 was 1.82M shares.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


PBLA) stock’s latest price update

Panbela Therapeutics Inc. (NASDAQ: PBLA)’s stock price has decreased by -12.04 compared to its previous closing price of 0.72. Despite this, the company has seen a fall of -19.23% in its stock price over the last five trading days.

PBLA’s Market Performance

Panbela Therapeutics Inc. (PBLA) has seen a -19.23% fall in stock performance for the week, with a -51.91% decline in the past month and a -84.06% plunge in the past quarter. The volatility ratio for the week is 13.80%, and the volatility levels for the past 30 days are at 12.90% for PBLA. The simple moving average for the last 20 days is -43.00% for PBLA stock, with a simple moving average of -96.78% for the last 200 days.

PBLA Trading at -68.07% from the 50-Day Moving Average

After a stumble in the market that brought PBLA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.28% of loss for the given period.

Volatility was left at 12.90%, however, over the last 30 days, the volatility rate increased by 13.80%, as shares sank -56.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -78.42% lower at present.

During the last 5 trading sessions, PBLA fell by -19.23%, which changed the moving average for the period of 200-days by -98.96% in comparison to the 20-day moving average, which settled at $1.0638. In addition, Panbela Therapeutics Inc. saw -78.51% in overturn over a single year, with a tendency to cut further losses.


In summary, Panbela Therapeutics Inc. (PBLA) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.